Introduction
The sex-determining region Y (SrY)-box (Sox) gene family encodes transcription factors characterized by HMgtype (high mobility group) Dna-binding domains (gubbay et al. 1990 ). Sox2 is a member of the SoxB1 family and regulates cell differentiation in various tissues (Sarkar and Hochedlinger 2013) . In early development, Sox2 deletion causes lethality due to the failure of the inner cell mass to form epiblasts and differentiates into trophectoderm (avilion et al. 2003) . In cancerous tissues, Sox2 is involved in tumor growth, promoting cancer cell proliferation and invasion in lung squamous cell carcinoma, esophageal squamous cell carcinoma, glioma, melanoma, and Merkel cell carcinoma (Bass et al. 2009; Ikushima et al. 2009; laga et al. 2010) .
In addition to a role in early development, Sox2 plays an important role in the central nervous system (CnS). Sox2 is a known neural stem cell marker and is found in the neurogenic region, specifically the embryonic neuroepithelial cells, the periventricular germinal (or subventricular) zone, and the adult hippocampal subgranular zone. Within the neurogenic region, Sox2 maintains the neural stem cell state by controlling proliferation and differentiation (Ferri et al. 2004; Bani-Yaghoub et al. 2006; Favaro et al. 2009 ). In the peripheral nervous system (PnS), Sox2 is observed in neural crest stem cells, regulating their migration, proliferation, and differentiation (Wakamatsu et al. 2004; Cimadamore et al. 2011) . However, Sox2 protein and its mrna have not been observed in the dorsal root ganglion (Drg) (aquino et al. 2006; li et al. 2007 ). In adult rat, dedifferentiated Schwann cells (SCs) are reported to re-express Sox2, thereby inhibiting myelination and regulating N-cadherin localization (Sarkar and Hochedlinger 2013) .
aside from these studies, localization of Sox2 protein and its mrna in the adult PnS has not been examined in other cell types, for example, non-myelinating and terminal SCs that contribute to sensory receptor organ formation. Therefore, in the present study, we identified Sox2 immunopositive cells in the adult rat PnS and used rT-PCr to confirm Sox2 mrna expression.
Materials and methods
animals eight-week-old male Wistar rats (250 g body weight) obtained from Shimizu laboratory Supplies (Kyoto, Japan) were used. The animal ethics Committee of Kansai Medical University approved all experimental protocols, and all studies were performed in accordance with the Principles of laboratory animal Care (nIH publication no. 85-23, revised 1985) .
Tissue preparation rats were deeply anesthetized with sodium pentobarbital (50 mg/kg i.p.). animals were perfused transcardially with 0.1 M phosphate buffer (PB, pH 7.4), followed by 4 % formaldehyde (Fa) in PB. lumber Drg, sciatic nerves (harvested from the middle thigh), the hind paw pad, and ear were removed and immersed in fixative for 12 h at 4 °C. after cryoprotection with 20 % sucrose in PB for 12 h at 4 °C, tissues were embedded in OCT compound and frozen with CO 2 gas. Cryostat sections of appropriate thickness (5, 20, or 35 μm) were prepared. Sections were stored at 4 °C in 0.1 M phosphate-buffered saline (PBS) with 0.02 % sodium azide until use.
Immunohistochemistry
Sections were rinsed in PBS containing 0.3 % Triton-X-100 (PBST) and incubated in primary antibodies diluted with PBST for 12 h at 4 °C. The primary antibodies used were the following: goat anti-Sox2 (1:1,000; Santa Cruz Biotechnology, Santa Cruz, Ca, USa), rabbit anti-Sox2 (1:400; Chemicon, Temecula, Ca, USa), rabbit anti-glutamine synthetase (gS) (1:10,000; Sigma, St. louis, MO, USa), mouse anti-S100 beta subunit protein (1:1,000; Sigma), rabbit anti-S100 (1:10,000; DakoCytomation, glostrup, Denmark), mouse anti-nestin (1:400; Chemicon), mouse anti-myelin basic protein (MBP) (1:1,000; UltraClone ltd., Cambridge, UK), mouse anti-p75 (1:2,000; abcam, Cambridge, UK), goat anti-CgrP (1:200; abcam), and rabbit anti-neurofilament 200 (nF200) (1:400; Sigma). We predominantly used the Santa Cruz antibody for Sox2 staining. after washing three times in 0.3 % PBST for 10 min at 20 °C, sections were incubated in Cy2-, Cy3-, and/or Cy5-labeled secondary antibodies specific to appropriate animals (1:200; Jackson Immunoresearch, West grove, Pa, USa). after washing three times in PBST, sections were mounted in medium containing 100 mM DTT, 5 μg/ml Hoechst dye 33258 (nacalai Tesque Inc., Tokyo, Japan), 50 % glycerol, and PBS. Fluorescent images were captured using a confocal microscope (lSM 510-MeTa, Carl Zeiss, Oberkochen, germany) with objective lens (Plan-aPOCHrOMaTO 63x oil).
For Sox2 signal intensity measuring, Drg, sciatic nerve, pad skin, and ear skin were harvested from 3 animals, individually. Fluorescence images of Sox2 were captured under same exposure condition using a fluorescence microscope (e600, nikon, Tokyo, Japan) with objective lens (PlanFluor 40x). Total Sox2 signal intensity and total pixel number were measured at nucleic area of appropriate glial cells (see results) using the image analysis software, MetaMorph (Molecular Devices, Sunnyvale, Ca, USa). The signal intensity/pixel was calculated in each glial cell type.
Semi-thin sections
Sciatic nerve cross sections (50 μm) were incubated in rabbit anti-p75 antibody (1:2,000), diluted in PBST, for 48 h at 4 °C. after washing three times in PBST, sections were incubated in biotinylated anti-rabbit Igg antibody (1:200; Vector lab, Burlingame, Ca, USa) for 4 h at 20 °C. next, samples were washed thoroughly in PBST and incubated with avidin-biotin complex (aBC) (Vector lab) for 3 h at 20 °C. aBC-peroxidase was visualized by incubation in 0.05 % diaminobenzidine in 0.05 M Tris-HCl buffer (pH 7.6) and 0.06 % H 2 O 2 , for 10 min. Sections were PBS washed, reacted with 1 % OsO 4 for 1 h, and then washed with distilled water, before dehydrating in ascending acetone and embedding in epon (lubeak 812). Semi-thin sections (1 μm) were counterstained with toluidine blue and observed using a light microscope (e1000M, nikon) with objective lens (Plan-apo 100x oil).
Control immunohistochemistry
Primary goat anti-Sox2 Igg antibody (1:1,000; Santa Cruz) was reacted with fivefold (by weight) blocking peptide (Santa Cruz) for 12 h at 4 °C before use. Sections were then reacted with primary antibody containing blocking peptide for 12 h at 4 °C. after washing with PBST three times for 10 min at 20 °C, sections were incubated in biotinylated goat anti-goat Igg antibody (1:200; Vector lab) diluted in PBST, for 2 h at room temperature, washed three times in PBST for 10 min, and incubated in aBC solution (Vector lab). Peroxidase was visualized by incubating in 0.05 % diaminobenzidine in 0.05 M Tris-HCl buffer (pH 7.2) and 0.06 % H 2 O 2 , for 7 min. Sections were then mounted, counterstained in hematoxylin, dehydrated with ascending ethanol, and coverslipped. Sections were observed using a light microscope (e1000M, nikon).
PCr
Total rna was extracted from Drg, the sciatic nerve, foot pad, and ear using Sepasol-rna I Super g (nacalai Tesque Inc.), according to the manufacturer's instructions. rna was reverse-transcribed into cDna using the QuantiTect reverse transcription kit (Qiagen K.K., Tokyo, Japan). reverse transcriptase (rT) negative samples were used as controls. PCrs were performed in a final volume of 50 μl with 0.25 M forward (5′-aCCggCggCaaCCagaa gaaCag-3′) and reverse (5′-gCgCCgCggCCggTaTT TaT-3′) primers (amplifying a 263-bp product), or forward (5′-agaaCCCCaagaTgCaCaaC-3′) and reverse (5′-aTgTaggTCTgCgagCTggT-3′) primers (amplifying a 466-bp product), cDna template and goTaq master mix (Promega Corporation, Madison, WI, USa). The PCr conditions used were as follows: an initial denaturation for 4 min at 95 °C, followed by 35 cycles of 95 °C for 30 s, 55 °C for 30 s and 72 °C for 30 s. PCr products were electrophoresed in 2 % agarose gels and visualized with gelred (Biotium, Inc., Hayward, Ca, USa). PCr product identity was confirmed by sequencing.
Results

Sox2 immunopositive cell distribution
We found two types of glial cells with the exception of SCs. They exhibited nuclear Sox2 immunoreactitvity (Fig. 1) . One glial cell type is well known, namely satellite glial cells (SgCs), flattened cells that cover the somata of both small and large Drg neurons (Fig. 1a-c) . all of them were Sox2 immunopositive. The other glial cell type (see "Discussion") covered large caliber axons not insulated by myelin sheath. In general, large caliber axons are covered with myelinating SCs and immunohistochemically identifiable with anti-MBP antibody; however, MBP immunoreactivity was absent in these cells (Fig. 1d-f) . To identify the initial location of these glial cells, large neurons and their large caliber axons were immunohistochemically stained with anti-nF200 and myelin sheaths with anti-MBP. Tracing nF-200-positive axons from their somata to the periphery identified non-myelinated axons proximal to neuronal somata ( Fig. 1g-i) . These non-myelinated axons were covered by glial cells (Fig. 1j-l) . all of these non-myelinating glial cells in Drg were Sox2 immunopositive.
Previous work has shown that p75 is expressed in cells of the non-myelinating SC lineage (Zorick et al. 1996) . In transverse sciatic nerve sections, all p75-positive cell nuclei showed Sox2 immunoreactivity (Fig. 2a-c) . In addition, pre-embedded p75 semi-thin sections identified small pored structures in p75-positive cytoplasm (Fig. 2d) , thereby identifying p75-positive cells as non-myelinating SCs possessing fine axons. Within Drg, myelinating SCs did not show Sox2 immunoreactivity (Fig. 1d-f) .
In the present study, we used anti-nestin and anti-S100 antibodies to detect terminal SCs. as shown by Su et al. (2013) , glial cells in the adult PnS are nestin positive. Moreover, sensory receptor organs are typically composed of an axon terminal covered by terminal SCs. We examined terminal SCs of lamellar corpuscles, longitudinal lanceolate endings, circumferential nerve endings, and free nerve endings. lamellar corpuscles were observed in dermal papillae of the foot pad skin and composed of an axon terminal with more than one terminal SC. Sox2 immunoreactivity was observed in the majority of nuclei within terminal SCs (Fig. 3a-c) . longitudinal lanceolate endings were situated around hair follicles, and circumferential nerve endings were rarely observed at collar regions of longitudinal lanceolate endings in ear skin. We found the nuclei of terminal SCs sheathing longitudinal lanceolate endings expressed Sox2, but not those surrounding circumferential nerve endings (Fig. 3d-f) . Free nerve endings located at the subepidermis were observed in the foot pad and auricle skin. Sox2 was not found in terminal SCs of free nerve endings (Fig. 3g-h ).
Sox2 immunoreactivity intensity was compared between SgCs, non-myelinating SCs, and terminal SCs (Fig. 4) . Sections harvested from each tissue were simultaneously stained and captured under the same exposure conditions. SgC nuclei around neurons and non-myelinating glial cells (described above) were strongly stained. non-myelinating SC nuclei showed very weak Sox2 immunoreactivity. Sox2 immunoreactivity in lamellar corpuscles and longitudinal lanceolate endings was stronger than non-myelinating SCs.
To confirm whether the tissues examined were intact or damaged, we identified inflammatory and apoptotic cells, because it is known that dedifferentiated SCs re-express Sox2 in injury sites (le et al. 2005 ). a small number of CD45-positive cells, representing leukocytes, were scattered in Drg and sciatic nerve. In the skin, many epidermal dendritic cells were CD45 positive. However, no abnormal leukocyte accumulation was observed in any tissue examined (Online resource 1, 2). Using TUnel staining to detect apoptopic cells, TUnel-positive cells were detected in the epidermal granular layer and hair follicles, regions with apoptopic cells under normal conditions. TUnel-positive cells were not found in either Drg or sciatic nerve (Online resource 1, 2).
rT-PCr results rT-PCr was performed on Drg, the sciatic nerve, foot pad, and ear to determine the presence of Sox2 mrna.
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Only a single 263-bp PCr product was detected in each tissue sample. We also observed single PCr products using another primer pair (Fig. 5a ). no PCr product was observed in rT-negative samples (Online resourse 1, 3). Sequencing of PCr products confirmed identical nucleotide sequences to the designed sequence. antibody specificity antibody immunoreactivity was absent when goat antiSox2 antibody was preabsorbed with blocking peptide (Fig. 5b, c) , demonstrating the reliability of our immunohistochemical results. Our immunohistochemical findings using goat (Santa Cruz) and rabbit (Chemicon) anti-Sox2 antibodies were identical (Fig. 5d, e) .
Discussion
We have identified, for the first time, Sox2 immunopositive cells in the adult rat sensory nervous system. Sox2 was observed in SgCs, and non-myelinating and terminal SCs of longitudinal lanceolate endings and lamellar corpuscles. Sox2 immunoreactivity intensity was strongest in SgCs and weak in non-myelinating SCs. no immunoreactivity was found in Drg neurons and terminal SCs of free or circumferential nerve endings. Simultaneous Sox2 protein and mrna localization corroborate the likelihood that these cells are Sox2 expressors.
In the adult CnS, Sox2 is expressed in neural stem/ progenitor cells, ependymal cells, and neurons located in the septum, thalamus, and striatum (Ferri et al. 2004) . We found that in the adult PnS, Sox2 is not expressed in Drg neurons but is found in specific glial cell populations, suggesting that in the sensory nervous system, Sox2 has a different physiological role than it does in the brain.
Sox2 immunopositive cell identification
Our immunohistochemical findings are reliable because: (1) two different Sox2-antibodies, obtained from different Fig. 1 Confocal microscopy images of rat Drg. Sections were immunohistochemically stained. a-c Stacked images of a section stained with anti-gS (green) and goat anti-Sox2 (red) antibodies. Flattened SgCs (green) cover ganglion neurons (n) with thin cytoplasm (arrowheads). Sox2 is observed in the nuclei of all SgCs. d-f Stacked images of a section stained with anti-S100 (green), goat antiSox2 (yellow) and -MBP (red) antibodies. a non-myelinating glial cell (arrow) and myelinating SC (arrowhead) sheathe a large caliber axon adjacent to a neuron. Sox2 is found in the nuclei of non-myelinating glial cells, but not myelinating SCs. g-i Section stained with anti-nF200 (green) and -MBP (red) antibodies. each image shows a different plane. an axon is traced according to the numbered arrowheads. The axon projects from a neuronal soma (n) (arrowhead 1) and is not covered with myelin sheath until arrow 4. j-l Section stained with anti-nF200 (red) and -S100 beta (green) antibodies. an axon is traced from the neuronal soma (n) according to the numbered arrowheads. The nF200-positive axon is covered by S100-positive glial cells. Dna, cyan. Scale bar 20 μm manufacturers, show the same results; (2) antibody specificity was confirmed with peptide neutralization; (3) the same results were obtained with both fluorescent-and enzyme-labeled immunohistochemistry; (4) Sox2 mrna was confirmed by rT-PCr; and (5) the accumulation of leukocytes or apoptotic cells was not found. Thus, Sox2 is expressed in the normal adult rat PnS.
Sox2 cell distribution
Our findings in Drg are in disagreement with the previous studies, which show no Sox2 mrna in rat (li et al. 2007 ), or protein in mouse (aquino et al. 2006 ). This discrepancy may be due to differing rT-PCr and immunohistochemistry conditions used in the studies.
Currently, S100 protein, glial fibrillary acidic protein, and gS are known SgC markers; however, they are not SgC-specific markers because SCs are also stained (Woodham et al. 1989; Miller et al. 2002; Miller 2004; Hanani 2005) . Therefore, we identified SgCs morphologically and found 2 glial cell types in Drg. One was a general SgC covering the neuronal soma. The other cell type was wrapped around nF200-positive axons, proximal to neuronal somata. all recent studies on SgCs have examined Fig. 3 Stacked confocal images of rat sensory receptor organs. a-f Sections stained with anti-nestin (green), -nF200 (red), and goat anti-Sox2 (magenta) antibodies. g-i Section stained with anti-S100 (green), -CgrP (red), and goat anti-Sox2 (red) antibodies. Terminal SCs are nestin or S100 positive, thick nerve fibers are nF200 positive, and free nerve endings are CgrP positive. a-c a lamellar corpuscle located apical of a dermal papilla. nuclei of the corpuscle are Sox2 positive (arrowheads). d-f lanceolate endings surrounding a hair follicle. Sox2 is detected within the nucleus of a terminal SC (arrowhead). g-i Section of free nerve endings. Terminal SCs do not express Sox2 (arrows). EP epidermis. DP dermal papilla. HF hair follicle. Dna, cyan. Scale bar 20 μm the first type of SgC. However, Pannese (1960) has shown two SgC types in the mammalian Drg (including adult rat), specifically perisomatic SgCs covering the neuronal cell body, and a periaxonal SgCs, wrapping the initial axonal projection of Drg neurons without myelin sheaths. This suggests that the second group of glial cells we have described are SgCs.
Sox2 expression has been observed in developing PnS ganglia using Sox2 β-geo mice (Zappone et al. 2000) . Prospective SgCs express Sox2 during Drg development (Wakamatsu et al. 2004; aquino et al. 2006) . Our results indicate Sox2 is expressed throughout the lifetime of both SgC types as in the enteric nervous system (Heanue and Pachnis 2011).
Sox2 expression is found in immature SCs from mouse sciatic nerve. Sox2 expression gradually decreases with development, although it is still present in adult sciatic nerve (le et al. 2005) . To date, the cells expressing Sox2 in adult sciatic nerve were not known. We immunohistochemically identified Sox2-positive cells in adult rat sciatic nerve as non-myelinating SCs, although expression levels are low (Fig. 4c, d ). Myelinating SCs do not show Sox2 immunoreactivity. Both myelinating and non-myelinating SCs are known to arise from immature SCs (Jessen and Mirsky 2005) and express Sox2 (Wakamatsu et al. 2000) . Our results indicate that Sox2 expression is maintained in the non-myelinating, but not myelinating, SC lineage.
In skin, Sox2 is expressed in skin-derived stem cells at dermal papillae and Merkel cells (Biernaskie et al. 2009; Driskell et al. 2009 ). Our histological observation discriminated terminal SCs from these cells, as the glial cells exhibited appropriate morphologies (Fig. 3) .
Terminal SCs cover the axon terminal and are the elements of sensory receptor organs. lamellar corpuscles are well distributed in dermal papillae in glabrous skin, and longitudinal lanceolate endings located at hair follicles (Jirmanova et al. 1997; Cauna 1969; Munger and Halata 1983) . We found that Sox2 is expressed in almost all terminal SCs of these two receptor organs. In contrast, Sox2 was not observed in terminal SCs of subepidermal and circumferential nerve endings. Subepidermal nerve endings are known to be free nerve endings (Cauna 1973) , and circumferential nerve endings are also considered free nerve endings (Kruger et al. 1981) . Thus, our results indicate that terminal SCs of free nerve endings are Sox2 negative, and that Sox2 is present in SCs found between restricted types of sensory receptor organs. . c Section stained with goat anti-Sox2 antibody pre-incubated with an antigenic peptide. no reaction product is seen, faint blue and hematoxylin. d, e Double immunohistochemistry using goat (d) and rabbit (e) anti-Sox2 antibodies. Positive reactions colocalize. Scale bar 20 μm Sox2 significance neurogenesis in the Drg is controversial. an increase in neuronal number during postnatal maturation has been reported (Popken and Farel 1997; Farel 2002 Farel , 2003 , although studies also report no change (la Forte et al. 1991; Pover et al. 1994) . It has been suggested that the increased neuronal number is caused by the maturation of post-mitotic immature cells, as BrdU-positive neurons have not been observed in Drg (Ciaroni et al. 2000; Farel 2003 ). However, recent in vitro experiments show BrdU-positive neurons and neurospheres in postnatal mouse and adult rat Drg (namaka et al. 2001; li et al. 2007 ). In neurogenic regions of developing or adult animals, Sox2 is expressed in neural stem and progenitor cells, and thereby maintains the stem cell state (graham et al. 2003; Ferri et al. 2004; Bani-Yaghoub et al. 2006; Suh et al. 2007) . neural progenitor cells require Sox2 at an early stage of differentiation, promoting Drg expression of proneural bHlH genes, including NGN1 and Mash1 (Cavallaro et al. 2008; Cimadamore et al. 2011) . We found Sox2 expression in SgCs of adult rat Drg, corroborating the previous finding that SgCs have the potential to generate neurospheres (li et al. 2007 ), although it is still unclear whether neurogenesis occurs in adult Drg.
recently, roles for Sox2 in the adult PnS were reported. Sox2 is a known negative regulator of myelin-related genes, via Krox20 (le et al. 2005; Parkinson et al. 2008) . ephB signaling regulates N-cadherin distribution though Sox2, arranging dedifferentiated myelinating SCs for axonal regeneration (Parrinello et al. 2010 ). Sox2 regulates p27 Kip1 , inhibiting inner pillar cell proliferation in neonatal and adult mouse cochlea (liu et al. 2012) . Thus, within the PnS, Sox2 plays a different role in each cell type. Moreover, we found Sox2 expression patterns and level differed among glial cell types in the sensory nervous system. These differing expression patterns suggest Sox2 plays a cell-specific role.
In conclusion, we have identified Sox2 in PnS glial cells, Sox2 was observed in SgCs, and non-myelinating and specific terminal SCs. although Sox2 was expressed in non-myelinating glial cells, it preferentially localized to less differentiated cells in Drg and sciatic nerve, and intricately shaped, highly differentiated terminal SCs in sensory receptor organs. These results indicate that the role of Sox2 is different in distinct glial cell populations.
